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ABSTRACT 
Inhibitors of carbohydrate-hydrolysing enzymes play an important role for the treatment of 
diabetes. One of the therapeutic methods for decreasing of postprandial hyperglycemia is to 
retard absorption of glucose by the inhibition of carbohydrate- hydrolysing enzymes, such as 
α-glucosidase, in the digestive organs. To investigate the therapeutic potential of compounds 
from natural sources, Callistephus chinensis flowers (CCF) were tested for inhibition of α-
glucosidase, and acarboes was used as the positive control. The 70 % ethanol extract of CCF 
exhibited significant α-glucosidase inhibitory activities with IC50 value of 8.14 μg/ml. The 
stepwise polarity fractions of CCF were tested further for in vitro inhibition of α-glucosidase. 
The ethyl acetate (EtOAc) fraction exhibited the most significant inhibitory activity. Eight 
pure compounds, apigenin, apigenin-7-O-β-D- glucoside, kaempferol, hyperin, naringenin, 
quercetin, luteolin, and kaempferol-7-O-β-D- glucoside, were isolated (using enzyme assay-
guide fractionation method) from the EtOAc fraction. Among these, quercetin was the most 
active one (IC50 values 2.04 μg/ml), and it appears that the inhibiting percentages are close to 
acarbose (IC50 values 2.24 μg/ml), the positive control, on α-glucosidase inhibition. 
HPLC/UV analysis indicated that the major components of CCF are kaempferol, hyperin and 
quercetin. The presented results revealed that CCF containing these eight flavonoids could be 
a useful natural source in the development of a novel α-glucosidase inhibitory agent against 
diabetic complications.  
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INTRODUCTION 
Over the past several decades, the prev-
alence of diabetes mellitus has increased 
dramatically worldwide (Gorelick et al., 
2011). According to some estimates, India, 
China, and United States will have the larg-
est number of diabetic people by the year 
2030 (Wild et al., 2004). The reasons for 
the rising prevalence are often linked with 
an increase in both obesity and ageing as 
well as genetic factors (Hui et al., 2010). 
Without proper and timely treatments, dia-
betes can result in many complications in-
cluding hyperglycemia, diabetic ketoacido-
sis, cardiovascular disease and chronic re-
nal failure (Yu et al., 2013). Accordingly, 
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active and adequate treatments are essential 
for diabetes.  
Adjustment of blood sugar is an effect 
approach and very important for diabetes 
control. The ideal final result for diabetes 
mellitus is to prevent the excessive rise of 
postprandial blood glucose. α-Glucosidas, 
wildly existed in the brush border surface of 
intestinal cells, is essential for carbohydrate 
digestion due to monosaccharides are only 
readily absorbed from the intestine. Other 
carbohydrates must be degraded enzymati-
cally before they can be absorbed (Kim, 
2013). The inhibitors of α-glucosidase 
could delay in the digestion of ingested car-
bohydrates and consequently lead to sup-
press the postprandial blood glucose (Hea-
cock et al., 2005).Therefore, α-glucosidase 
inbibitors have promise as therapeutic 
agents for type 2 non-insulin-dependent di-
abetes mellitus (Baron, 1998). However, 
current glucosidase inhibitions such as 
acarbose and miglitol for diabetes manage-
ment are not fully satisfactory and pro-
longed use often causes some serious side 
effects, particularly with diarrhea (Lebovitz, 
1997) and corresponding intestinal pain and 
flatulence (Fujisawa et al., 2005). Random-
ized controlled trials with glucosidase inhi-
bitions report these gastrointestinal side ef-
fects as the most common reason for non-
compliance and early subject withdrawal 
(Neuser et al., 2005). Consequently, re-
searchers have increasingly focused on 
finding more effective and safe α-
glucosidase inhibitors from natural materi-
als to develop physiological functional food 
to treat diabetes (Bhandari et al., 2008; Liu 
et al., 2011; Matsuura et al., 2002; Nishioka 
et al., 1998; Wang et al., 2010), such as 
polyphenols from fruits (Jiang et al., 2013), 
isoflavones from soybean (Niamnuy et al., 
2011), and hydrolysate from sardine muscle 
(Matsui et al., 1996).  
Callistephus chinensis, which belongs 
to the Asteraceae family, is extensively 
grown in both the northern and southern 
parts of China. Since its flowers possess 
high ornamental value, C. chinensis are 
now widely cultivated in many countries. 
Several studies have demonstrated that the 
Asteraceae family display strong biological 
activity, such as anti-diabetes, antioxidant 
effects and inhibitory effects against bacte-
ria and viruses, and at the same time can al-
so prevent indigestion, pneumonia, hepatitis 
and tumors (Cheng et al., 2005; Gorzalcza-
ny et al., 2013; Kim et al., 2013; Matsuda et 
al., 2002; Zhu et al., 2005; Yan et al., 1999). 
However, to our knowledge, no study has 
been done to determine the anti-diabetic ac-
tivity of Callistephus chinensis flower 
(CCF). Thus, this present study investigates 
the chemical constituents of CCF and their 
anti-diabetic activity and aim to find new 
natural source for the development of α-
glucosidase inhibitory agent for dealing 
with diabetic complications. 
 
MATERIALS AND METHODS 
Plant materials and chemicals 
The flowers of Callistephus chinensis 
were collected form Inner Mongolia Auton-
omous Region, Republic of China, in 2012 
and were kept in desiccators after they had 
been air dried. All the solvents for the ex-
traction were purchased from Qingdao Hai-
yang Chemical Co., Ltd. 1H- and 13C-NMR 
spectra were recorded on a Bruker 
AVANCE 600 NMR spectrometer (Rhein-
stetten, Germany). Reagents and solvents 
including α-glucosidase from recombinant 
Saccharomyces cerevisiae (expressed in un-
specified host), α-amylase from Bacillus li-
cheniformis, 4-nitrophenyl α-D-glucopyra-
noside, starch, potassium phosphate buffer, 
and dimethyl sulfoxide (DMSO) were pur-
chased from Sigma–Aldrich (St. Louis, MO, 
USA). Acarbose, used as a standard, was 
produced by the Bayer Company in Ger-
many. 
 
Preparation of extracts  
C. chinensis flowers (CCF, 8 kg) were 
ground to fine a powder and then extracted 
with 8 L of 70 % ethanol for 2.5 h under re-
flux at 50 °C. After extraction, the solvent 
was removed by vacuum filtration, and the 
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70 % ethanol extract (265 g) was collected. 
The aqueous solution was extracted fol-
lowed by n-hexane, CH2Cl2, EtOAc and n-
BuOH to get layer of EtOAc (73.5 g). 
 
Isolation of active compounds from 
EtOAc-soluble fraction 
The EtOAc fraction (70 g) was subject-
ed to purification by silica gel (1200 g) col-
umn chromatography using CH2Cl2:MeOH 
solvent system with increased polarity 
(from 0:100 to 100:0, v/v). The eluent was 
collected into ten fractions. Fraction 4 
(1.2 g) was applied to a Shephadex LH-20 
column and eluted with MeOH to give 
compound 3 (37 mg) and 5 (14 mg) after 
recrystallisation with MeOH. Fraction 6 
(4.7 g) was again purified by silica gel col-
umn to yield compound 1 (22 mg) and 6 
(112 mg). Fraction 9 (9.2 g) was further pu-
rified by silica gel column and Sephadex 
LH-20 column to yield compound 2 (17.0 
mg), 4 (24.0 mg) and 8 (7.8 mg). 
 
Assay for α-glucosidase inhibitory activity  
α-Glucosidase inhibitory activity of 
samples was performed using a previously 
described method (Kim et al., 2004; Yu et 
al., 2013), with slight modification. Thirty 
microliter of the α-glucosidase solution (2 
units mL-1, 0.1 mol L-1 potassium phos-
phate buffer, pH 6.8) was pre-mixed with 
20 μL of the purified compound at different 
concentrations (in 1 % DMSO) and incu-
bated at 37.5 °C for 5 min, 150 μL of p-
nitrophenyl glucopyranoside (pNPG, 
10 mM) and 800 μL of 0.1 M potassium 
phosphate buffer were added to the mixture 
to start the reaction. After another thirty 
minutes’ incubation at 37.5 °C, 2 mL of 
1 M Na2CO3 was added to per test tube for 
termination (Yu and Yin, 2011a; b). The ab-
sorbance of the sample at 405 nm was mea-
sured to quantify the amount of released 
product (p-nitro phenol) used by microplate 
Reader (varioskan flash-3001, Thermo Sci-
entific, USA). Three parallel operations 
were done. Acarbose was used as positive 
control. Inhibition of α-glucosidase activity 
by each of the compound was expressed 
relative to control (no inhibitor).  
 
Sample preparation and quantitative  
analysis of flavonoids in CCF 
To quantify the amount of compounds 
1-8 in CCF extract, 2 mg of each extract 
was dissolved in 1 mL MeOH. The result-
ant solutions were filtered through a What-
man 0.45 μm PVDF syringe filter (Cat No. 
6779, NJ, USA) prior to HPLC. The HPLC 
separation of compounds 1–8 in CCF ex-
tracts for quantitative analysis was per-
formed using a reverse phase column (Dis-
covery C18, 5 μm, 250 × 4.6 mm, Chuang-
xintongheng, China) and a mobile phase 
phase consisted of acetonitrile and water 
(v/v). The gradient solvent system was 
13:87, initially, and was increased in linear 
gradients to 45: 65 over 65 min. The flow 
rate was kept constant at 1.0 mL/min, and 
the eluent was monitored by UV absorb-
ance at 210 nm. 
 
Limit of detection and quantification of 
flavonoids in CCF 
In general, limit of detection (LOD) and 
limit of quantification (LOQ) were used to 
validate the HPLC method. Determination 
of LOD and LOQ values were usually 
based on the linear regression equation and 
calculated by signal-to-noise ratio of ≥ 3 
and ≥ 10, respectively. 
 
Calibration curves and statistical analysis  
The calibration curves and statistical 
analysis were referred to a previously de-
scribed method (Mok et al., 2013) with 
slight modification. Each of eight pure iso-
lated compounds were prepared in MeOH 
(2 mg/mL) and repeatedly mixed with the 
same solvent. The concentration of com-
pounds 1-8 was verified by comparing the 
individual peak areas of each sample to 
those of the corresponding standards. Cali-
bration curves were obtained based on peak 
area (Y) as vertical coordinates and concen-
tration (X, mg/mL) as horizontal axis. Data 
were expressed as mean ± S.D. of three re-
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plicate determinations for each sample with 
different concentrations (n = 5). The inhibi-
tory activities of the samples are described 
as inhibitory concentration 50 % (IC50) and 
calculated using SPSS program. Statistical 
significance was calculated by one-way 
analysis of variance (ANOVA) method and 
Dunnett’s test. 
 
RESULTS AND DISCUSSION 
α-Glucosidase activity of the extract and 
fractions from CCF 
The different fractions partitioned from 
the 70 % ethanol extract were tested for the 
presence of inhibitory activity against α-
glucosidase, and the results are summarized 
in Table 1 and Figure 1. As the EtOAc frac-
tion showed obviously higher inhibitory ac-
tivities than did the 70 % ethanol extract 
against α-glucosidase, we supposed that the 
main active compositions of the 70 % etha-
nol extract of CCF were basically in the 
EtOAc fraction. Meanwhile, the data shown 
that the EtOAc fraction exhibited signifi-
cant α-glucosidase inhibition, with an IC50 
value of 2.97 μg/mL. In previous papers, 
flavonoid compounds from the leaves of 
fruits and grape seeds have been of increas-
ing interest due to their anti-diabetic prop-
erties (Wang et al., 2010; Han et al., 2012; 
Kar et al., 2009; Montagut et al., 2010). 
Although extracts of the Asteraceae family 
plants have been reported to exhibit signifi-
cant hepatic protective activity (Jeong et al., 
2013), few studies have reported on the an-
ti-diabetic activities of CCF. 
 
Isolation of active compounds and  
structural determination 
The EtOAc soluble portion of the 70 % 
ethanol extract from CCF was then subject-
ed to repeated rounds of silica gel and 
Shephadex LH-20 chromatography, result-
ing in the isolation of compounds 1–8. The 
structural determination of isolated com-
pounds was confirmed by a combination of 
1H-, 13C-NMR (Table 2). The singlet signals 
at δ 12.02-12.91 observed in the 1H-NMR 
spectra of compounds 1–8 showed 5-OH of 
an A-ring in their structures. The signals of 
typical structures in flavonoids were shown 
in 13C-NMR spectra and compared with 
values in the literature (Agrawal, 1989; 
Agrawal and Bansal, 1989; Andersen and 
Markham, 1989; Crow et al., 1986; Mok et 
al., 2013; Markham et al., 1978; Park et al., 
2006; Harborne and Williams, 1993; Ya-
sukawa et al., 1989). Based on the spectro-
scopic data obtained, the chemical struc-
tures of the purified  compounds were iden- 
 
Table 1: IC50 values of the fractions and compounds 1-8 from CCF for inhibition of α-glucosidase 
Extract and Frac-
tions 
IC50a 
(μg/mL) Compounds from EtOAc 
IC50a 
(μg/mL) 
Extract 8.14 1 apigenin 25.47 
n-Hexane 84.33 2 apigenin-7-O-glucoside 29.73 
CH2Cl2 34.54 3 kaempferol 16.97 
EtOAc 2.97* 4 hyperin 19.26 
n-BuOH 77.89 5 naringenin 57.40 
  6 quercetin 2.04* 
  7 luteolin 43.57 
  8 kaempferol-7-o-β-D-glucoside 20.68 
  Acarboseb 2.24 
a IC50 value was calculated from the least-squares regression equations in the plot of the logarithm of three 
graded concentrations vs.% inhibition;  
b Acarbose was used as a positive control; * Means p< 0.05 compared with acarbose 
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Figure 1: α-Glucosidase inhibition by extract, fractions, compounds 1-8 and acarbose:  
(a) α-glucosidase inhibition by extract, fractions and acarbose. (b) α-glucosidase inhibition by com-
pounds 1-8 and acarbose. (c) α-glucosidase inhibition by compound 6, EtOAc fraction and acarboes 
a 
c 
b 
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tified as apigenin (1), apigenin-7-O-
glucoside (2), kaempferol (3), hyperin (4), 
naringenin (5), quercetin (6), luteolin (7), 
kaempferol-7-O-β-D-glucoside (8) (Figure 
2). Although common flavonoids have been 
isolated from various plants, to our 
knowledge, this is the first report on the iso-
lation of phytochemical constituents from 
CCF. 
 
Inhibition of α-glucosidase activity 
Compounds 1-8 were tested for their in-
hibitory activity against α-glucosidase at 
four different concentrations. Comparing 
the activities of isolated compounds with 
those of the fractions, in particular, our re-
sults shown that the quercetin (6) was the 
main active constituent of CCF, it appears 
that the inhibiting percentages of isolated 
compounds are close to acarbose, the posi-
tive control, on α-glucosidase inhibition. 
The IC50 values were shown in Table 1 and 
the inhibiting percentages of the fractions 
and isolated compounds were shown in Fi-
gure 1. In addition, many flavonoids and 
phenol constituents with strong inhibitory 
activity toward α-glucosidase have been 
previously reported (Kawanishi et al., 2003; 
Lee and Kim, 2008; Yawadio et al., 2007). 
All the eight compounds isolated from CCF 
are the typical structures in flavonoids, but 
among them, only the flavonols (com-
pounds 3, 6 and 8) showed higher α-gluco-
sidase inhibitory activity than the flavonoid.  
 
Table 2: 13C-NMR spectral data for compounds 1-8 (DMSO-d6) from CCF 
No. 1 2 3 4 5 6 7 8 
Compound apigenin 
apigenin- 
7-O-
glucoside 
kaempferol hyperin naringenin quercetin luteolin 
kaempferol-
7-O-β-D-
glucoside 
C-2 164.0 164.7 145.5 156.3 79.7 146.5 165.5 147.6 
C-3 102.7 103.5 135.6 134.1 43.5 135.6 103.9 136.2 
C-4 181.2 181.8 176.0 177.6 197.2 176.3 183.8 176.5 
C-5 161.9 162.7 161.3 161.7 165.2 161.4 163.8 160.3 
C-6 99.2 99.2 99.5 98.6 95.8 97.8 100.5 98.9 
C-7 163.3 161.0 163.7 164.6 167.9 164.2 166.7 162.4 
C-8 93.6 94.5 94.3 93.2 96.7 93.5 95.7 94.5 
C\-9 157.0 156.8 157.1 156.7 164.5 156.7 159.5 155.9 
C-10 103.3 105.2 101.6 103.9 103.2 103.5 105.6 104.3 
C-1' 121.9 121.1 122.3 122.0 128.8 120.7 1207 121.2 
C-2' 128.3 128.3 129.5 116.0 130.6 114.8 114.6 129.8 
C-3' 115.8 116.3 115.9 145.1 116.1 146.9 146.5 115.5 
C-4' 161.6 161.5 159.9 149.0 158.5 147.8 150.7 159.4 
C-5' 115.8 116.6 115.9 116.3 116.1 115.7 117.2 115.5 
C-6' 128.3 128.3 129.5 121.8 130.5 120.0 123.6 129.7 
C-1' - 98.5 - 101.5 - - - 99.8 
C-2'' - 73.7 - 74.7 - - - 73.4 
C-3'' - 76.1 - 77.3 - - - 77.3 
C-4'' - 69.2 - 70.6 - - - 69.7 
C-5'' - 77.6 - 77.2 - - - 76.5 
C-6'' - 60.5 - 61.4 - - - 60.8 
EXCLI Journal 2013;12:956-966 – ISSN 1611-2156 
Received: August 18, 2013, accepted: November 07, 2013, published: November 19, 2013 
 
 
962 
Di-hydroxy flavonoids in a B-ring (com-
pounds 4 and 6) showed more significant 
inhibitory activity against α-glucosidase 
than other mono-hydroxy flavonoids. The 
most interesting is that compound 6 con-
taining di-hydroxyl groups B-rings and 3-
OH in the skeleton exhibited the highest α-
glucosidase inhibitory activity (IC50 values 
2.04 μg/mL). 
 
Quantitative analysis, LOD, and LOQ of 
flavonoids in CCF 
The concentrations of compounds 1–8 
in CCF were determined by HPLC/UV. The 
HPLC chromatograms of the mixture of 
eight pure compounds and EtOAc-soluble 
extract are shown in Figure 3. The calibra-
tion equations and retention times are 
shown in Table 3. The retention time of the 
expected peak for each of the compounds 
(1–8) purified from CCF was the same as 
that of the corresponding standard com-
pounds. Kaempferol (3) and quercetin (6) 
were the major flavonols in CCF (Figure 3). 
The LOD and LOQ were 0.05-3.65 and 
0.19-12.20 μg/mL determined at the signal-
to-noise ratio S/N of 3 and 10, respectively, 
in CCF (Table 4). The HPLC profiles of the 
EtOAc fraction indicated that kaempferol (3) 
and quercetin (6) are the major components, 
and they play a crucial role in α-glucosidase 
inhibition.  
 
O
OH
R4
O
R2
R3
R1
1. R1=H, R2=OH, R3=H, R4=OH
2. R1=H, R2=-O-Gla, R3=H, R4=OH
3. R1=OH, R2=OH, R3=H, R4=OH
4. R1=-O-Gla, R2=OH, R3=OH, R4=OH
6. R1=OH, R2=OH,R3=OH, R4=OH
8. R1=OH, R2=-O-Gla, R3=H, R4=OH
O
OH
OH
O
HO
5. R=H
7. R=OH
R
 
Figure 2: Structures of compounds 1-8 from CCF 
 
Table 3: Linearity of standard curves and sensitivity of compounds 1-8 in CCF 
Compounds tR Calibration equationa 
Correlation 
factor. r2b 
LOD 
(μg/mL) 
LOQ 
(μg/mL) 
1 apigenin 50.7 Y = 4476676.4 X – 1764378.6 0.9990 0.15 ± 0.25 0.19 ± 0.06
2 apigenin-7-O-
glucoside 29.4 Y = 4676100.5 X – 528330.2 0.9994 0.11 ± 0.06 0.36 ± 0.14
3 kaempferol 51.3 Y = 5566328.6 X + 497849.6 0.9993 0.05 ± 0.10 0.19 ± 0.08
4 hyperin 22.3 Y = 5784705.0 X – 126647.1 0.9992 0.05 ± 0.09 0.18 ± 0.07
5 naringenin 53.3 Y = 23190444.8 X – 12597665.0 0.9997 0.35 ± 0.08 1.17 ± 0.13
6 quercetin 43.2 Y = 4117828.7 X – 3801255.7 0.9990 3.65 ± 0.22 12.20 ± 0.49
7 luteolin 41.7 Y = 4257791.7 X + 904356.9 0.9992 0.16 ± 0.09 0.55 ± 0.17
8 kaempferol-7-O-
β-D-glucoside 28.3 Y = 1081875.9 X – 520795.9 0.9995 2.01 ± 0.37 15.38 ± 2.36
a: Y = peak area, X = concentration of standards (mg/ml); b: r2 = correlation coefficient for three data points in the calibration 
curves ( n = 5). Data are means ± S.D. (n = 5) in mg/ml dried sample. 
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Figure 3: (a) HPLC chromatograms of the mixture of eight pure compounds. (b) HPLC chromato-
grams of EtOAc-soluble extract. (c) Quantities of compounds 1-8 in CCF 
a 
b 
c 
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Table 4: Quantities of compounds 1-8 in CCF 
Compounds CCF (μg/g) 
1 apigenin 1.01 ± 0.08 
2 apigenin-7-O-
glucoside 4.52 ± 0.28 
3 kaempferol 10.15 ± 1.36 
4 hyperin 13.43 ± 0.05 
5 naringenin 0.54 ± 0.17 
6 quercetin 27.87 ± 0.72 
7 luteolin 1.26 ± 0.17 
8 kaempferol-7-O-β-D-
glucoside 1.30 ± 0.15 
Values represent the means ± standard devia-
tion (S.D.) of n = 5 duplicate assays. 
 
CONCLUSIONS 
This is the first study on the utilization 
of CCF as an anti-diabetic source. Our data 
suggest that CCF extract could be used as a 
viable alternative to pharmaceutical inhibi-
tors for the inhibition of α-glucosidase ac-
tivity, since CCF is well tolerated and rela-
tively inexpensive. It is a good source of 
anti-diabetic agents, to which flavonols 
make an important contribution. The data 
also pointed out that CCF containing these 
flavonoids could be a useful natural source 
for the development of α-glucosidase inhib-
itory agent for dealing with diabetic com-
plications. Further investigations will focus 
on clarifying the anti-diabetes activity 
mechanisms of the isolated compounds. 
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